Month: June 2025

ZaiLab_EN_logo_-XL-RGB

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting

DaiichiSankyo-logo

ENHERTU® Plus Pertuzumab Reduced the Risk of Disease Progression or Death by 44% Versus THP as First-Line Therapy in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast09 Phase 3 Trial

guidewire_logo_new_2color_h_screen-2022

Guidewire Wins Six XCelent Awards and ‘Luminary’ Distinction in Celent’s Regional Reviews of P&C Policy Administration Systems

SAN MATEO, Calif.--(BUSINESS WIRE)--#XCelent--Guidewire (NYSE: GWRE) announced that Guidewire PolicyCenter has been selected as a winner of six Celent XCelent...